The artificial retina is a major breakthrough in the medical device industry, with several medical device companies and universities conducting research.
SEATTLE, WASHINGTON, UNITED STATES, December 31, 2021 /EINPresswire.com/ – Another factual information about the “𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐑𝐞𝐭𝐢𝐧𝐚 𝐌𝐚𝐫𝐤𝐞𝐭” was recently added by CMI to its warehouse. This research report offers an in-depth examination of various perspectives, for example, market patterns, parts of the overall industry, drivers, restraints, opportunities. It gives a survey view to settle other choices in organizations. It covers comprehensive informative information on various key players working around the world.
The artificial retina is a major breakthrough in the medical device industry, with several medical device companies and universities conducting research to provide vision to more than 285 million visually impaired people around the world. The artificial retina is a carbon nanotige-nanotube biomimetic film supplied with a video processing unit and a transmitter. The development of the artificial retina is expected to generate a high return on investment (ROI). So, market players are increasingly investing in research and development for the same, as these devices are expected to respond to a variety of vision disorders, such as retinitis pigmentosa (RP) and macular degeneration related to l ‘age (AMD). In 2016, more than 100,000 people in the United States suffered from retinitis pigmentosa (RP).
𝐓𝐈𝐌𝐄 𝐎𝐅𝐅𝐄𝐑 – 𝐔𝐩 !!!
With the advent of this new technology, market opportunities may open up for the players. For example, in 2013, the United States Food and Drug Administration (FDA) approved the first implanted device to treat RP, called the Argus II Retinal Prosthesis System.
Market players invest in research and development to capitalize on long-term lucrative opportunities through patented products and innovative technologies. the artificial retina market has also seen the rise of various startups, notably in the United States and Israel.
The increasing prevalence of visual impairment and increasing healthcare expenditure are expected to drive the growth of the global artificial retina market during the forecast period. According to the United States government, the healthcare sector is expected to contribute around 20% of overall GDP (gross domestic product). Additionally, the growing implementation of Medicare and Obamacare in the United States is expected to drive market growth, followed by Europe.
The major players active in the global artificial retina market are 𝐒𝐞𝐜𝐨𝐧𝐝 𝐒𝐢𝐠𝐡𝐭𝐬, 𝐍𝐚𝐧𝐨-𝐑𝐞𝐭𝐢𝐧𝐚, 𝐚𝐧𝐝 𝐎𝐩𝐭𝐨𝐛𝐢𝐨𝐧𝐢𝐜𝐬, 𝐚𝐦𝐨𝐧𝐠 𝐨𝐭𝐡𝐞𝐫𝐬.
Moreover, government initiatives for the development of artificial retina are expected to propel the growth of the global artificial retina market. Government organizations and medical device companies are collaborating to develop an artificial retina for the visually impaired population. For example, the US government started the DOE Artificial Retina Project to develop artificial retinas for the visually impaired.
𝐇𝐞𝐫𝐞 𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 @ https://www.coherentmarketinsights.com/insight/request-sample/13
Strict regulatory framework and patent issues are expected to hamper the growth of the global artificial retina market.
Advances in artificial retina are expected to create lucrative growth opportunities for market players.
North America and Europe are expected to experience robust growth in the global artificial retina market due to increased research and development and robust healthcare infrastructure in these regions. In North America, the healthcare industry is undergoing a major transformation due to the implementation of various healthcare reforms. More than 50,000 Americans go blind each year in North America. The region is home to a population of over 10 million visually impaired people seeking effective treatment.
Additionally, Asia-Pacific is expected to experience robust growth in the global artificial retina market due to the increasing prevalence of visual impairment in this region. For example, the region is home to over 55% of the world’s visually impaired population. The prevalence of RA is high in this region.
In August 2018, the research team at Seoul National University and the University of Texas at Austin developed and tested the world’s first ultra-thin artificial retina that could improve existing implantable visualization technology for the blind.
In July 2019, Leben Care raised angel funding from IP Ventures to tackle preventable blindness. Leben Care will use the funds to strengthen its product, sales and marketing teams.
In July 2019, Altris, Inc. received CE mark approval for its standard functionality for detecting retinal conditions on optical coherence tomography (OCT) scans.
𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐎𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 @ https://www.coherentmarketinsights.com/insight/request-pdf/13
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, custom research reports, and advisory services. We are known for our actionable insights and authentic reports in a variety of fields including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually every field. and a comprehensive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reporting. We are also committed to playing a leading role in providing insight into various post-COVID-19 sectors and continue to deliver measurable and sustainable results to our clients.